Superiority of 3D-DIR over 3D-FLAIR in the Detection of Cortical Lesions and Correlation with Disability in Multiple Sclerosis: A Multicenter Study

3D-DIR 在检测皮质病变方面优于 3D-FLAIR 以及与多发性硬化症残疾程度的相关性:一项多中心研究

阅读:1

Abstract

Background/Objectives: The aim of the study was to compare diagnostic performance of 3D-Double Inversion Recovery (DIR) and 3D-Fluid-Attenuated Inversion Recovery (FLAIR) sequences in the detection of brain lesions in Multiple Sclerosis (MS) patients, especially cortical ones, and to evaluate potential correlation between lesion number and clinical outcome. Methods: From April 2021 to July 2024, 278 MS patients (201 females, 77 males, mean age 47.01 ± 12.668 years) underwent brain MRI in three Italian Institutions using 1.5 T systems; 3D-FLAIR and 3D-DIR sequences were obtained with an identical anatomic position. Clinical disability was evaluated by the expanded disability state score (EDSS). Data analysis was performed using the Wilcoxon test for lesion count differences (primary endpoint), and Chi-square test and Spearman for EDSS correlation (secondary endpoint); a p < 0.05 was considered as statistically significant. Results: A significantly higher total number of lesions was displayed on DIR images (n = 6601) compared with FLAIR (n = 6484) (p < 0.001). The mean number of cortical lesions identified with DIR (1.56 ± 2.767) was significantly higher than the mean number of cortical lesions detected with FLAIR (0.52 ± 1.029) (p < 0.001). Conversely, FLAIR sequences detected a significantly higher mean number of subcortical lesions (9.34 ± 8.663) compared to DIR (8.94 ± 8.415) (p < 0.001). A significant correlation was found between EDSS and the number of juxtacortical and cortical lesions detected with DIR with a p < 0.001. Conclusions: 3D-DIR is superior to 3D-FLAIR in detecting cortical lesions, which are correlated to clinical disability, and it should be implemented for the diagnosis and prognostic evaluation in MS patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。